- Corporate Officers - B
- Barer Sol J
Insider Trading History of Barer Sol J
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Barer Sol J since 2006.
This trader's CIK number is 1247015.
At the time of last reporting, Barer Sol J was the Officer of Teva Pharmaceutical Industries Ltd. (stock ticker symbol TEVA).
Also see all insider trading activities at Teva Pharmaceutical Industries Ltd.
Note that in the past
BARER SOL J also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Pds Biotechnology Corp (EDGE) by Barer Sol J
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2019 | EDGE | 0 | $0 | 0 | $0 | 20,000 | $0 |
| 2015 | EDGE | 45,000 | $495,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Neximmune, Inc. (NEXI) by Barer Sol J
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2023 | NEXI | 400,000 | $164,000 | 0 | $0 | 0 | $0 |
| 2022 | NEXI | 400,000 | $548,582 | 0 | $0 | 0 | $0 |
| 2021 | NEXI | 60,000 | $1,020,000 | 0 | $0 | 50,000 | $258,500 |
Yearly summary of insider trading at Celgene Corp /de/ (CELG) by Barer Sol J
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2011 | CELG | 0 | $0 | 75,200 | $4,315,126 | 167,678 | $2,859,870 |
| 2010 | CELG | 0 | $0 | 0 | $0 | 169,016 | $7,164,588 |
| 2009 | CELG | 0 | $0 | 600,000 | $31,274,400 | 600,000 | $3,868,800 |
| 2008 | CELG | 0 | $0 | 1,233,516 | $77,566,030 | 1,038,640 | $11,900,527 |
| 2007 | CELG | 0 | $0 | 463,770 | $27,416,865 | 7,892 | $105,886 |
| 2006 | CELG | 0 | $0 | 0 | $0 | 1,346,196 | $16,436,723 |
Yearly summary of insider trading at Amicus Therapeutics, Inc. (FOLD) by Barer Sol J
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2013 | FOLD | 25,000 | $85,000 | 0 | $0 | 0 | $0 |
| 2009 | FOLD | 20,000 | $82,600 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Aevi Genomic Medicine, Llc (GNMX) by Barer Sol J
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2019 | GNMX | 0 | $0 | 4,098,752 | $549,232 | 0 | $0 |
| 2018 | GNMX | 2,551,020 | $2,448,979 | 0 | $0 | 0 | $0 |
| 2017 | GNMX | 621,032 | $841,500 | 0 | $0 | 0 | $0 |
| 2015 | GNMX | 353,846 | $2,537,998 | 0 | $0 | 0 | $0 |
| 2014 | GNMX | 453,854 | $2,137,237 | 0 | $0 | 0 | $0 |
| 2013 | GNMX | 105,000 | $650,805 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Inspiremd, Inc. (NSPR) by Barer Sol J
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2016 | NSPR | 847,458 | $500,000 | 0 | $0 | 0 | $0 |
| 2015 | NSPR | 2,500,000 | $0 | 0 | $0 | 0 | $0 |
| 2014 | NSPR | 242,308 | $122,115 | 0 | $0 | 0 | $0 |
| 2013 | NSPR | 900,000 | $1,813,399 | 0 | $0 | 0 | $0 |
| 2012 | NSPR | 100,000 | $131,047 | 0 | $0 | 0 | $0 |
| 2011 | NSPR | 0 | $0 | 0 | $0 | 1,000,000 | $1,500,000 |
Yearly summary of insider trading at Teva Pharmaceutical Industries Ltd (TEVA) by Barer Sol J
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2024 | TEVA | 0 | $0 | 0 | $0 | 37,598 | $0 |
| 2023 | TEVA | 0 | $0 | 0 | $0 | 28,162 | $0 |
| 2022 | TEVA | 0 | $0 | 0 | $0 | 25,791 | $0 |
| 2021 | TEVA | 0 | $0 | 0 | $0 | 22,565 | $0 |
| 2020 | TEVA | 0 | $0 | 0 | $0 | 56,991 | $0 |
| 2019 | TEVA | 215,500 | $2,000,410 | 0 | $0 | 2,780 | $0 |
| 2018 | TEVA | 0 | $0 | 0 | $0 | 2,162 | $0 |
Yearly summary of insider trading at Contrafect Corp (CFRX) by Barer Sol J
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2017 | CFRX | 40,000 | $49,600 | 0 | $0 | 0 | $0 |
Insider trading activities at 8 companies by Barer Sol J:
1. Pds Biotechnology Corp (EDGE)
2. Neximmune, Inc. (NEXI)
3. Celgene Corp /de/ (CELG)
4. Amicus Therapeutics, Inc. (FOLD)
5. Aevi Genomic Medicine, Llc (GNMX)
6. Inspiremd, Inc. (NSPR)
7. Teva Pharmaceutical Industries Ltd (TEVA)
8. Contrafect Corp (CFRX)
Table 1. Insider trading of Pds Biotechnology Corp (EDGE) by Barer Sol J
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2019-03-15 | EDGE | Option Ex | 20,000 | .00 | 0 |
| 2015-10-06 | EDGE | Buy | 45,000 | 11.00 | 495,000 |
Table 2. Insider trading of Neximmune, Inc. (NEXI) by Barer Sol J
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2023-03-30 | NEXI | Buy | 400,000 | .41 | 164,000 |
| 2022-11-16 | NEXI | Buy | 125,000 | .48 | 60,250 |
| 2022-11-17 | NEXI | Buy | 75,000 | .48 | 35,925 |
| 2022-06-01 | NEXI | Buy | 40,000 | 2.35 | 94,160 |
| 2022-06-02 | NEXI | Buy | 20,720 | 2.23 | 46,102 |
| 2022-05-31 | NEXI | Buy | 39,280 | 2.19 | 85,905 |
| 2022-03-23 | NEXI | Buy | 10,000 | 2.67 | 26,650 |
| 2022-03-22 | NEXI | Buy | 30,000 | 2.41 | 72,300 |
| 2022-03-21 | NEXI | Buy | 30,000 | 2.14 | 64,080 |
| 2022-03-18 | NEXI | Buy | 30,000 | 2.11 | 63,210 |
| 2021-12-21 | NEXI | Option Ex | 50,000 | 5.17 | 258,500 |
| 2021-02-17 | NEXI | Buy | 60,000 | 17.00 | 1,020,000 |
Table 3. Insider trading of Celgene Corp /de/ (CELG) by Barer Sol J
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2011-01-13 | CELG | Option Ex | 108,534 | 26.35 | 2,859,870 |
| 2011-01-13 | CELG | Sale | 75,200 | 57.38 | 4,315,126 |
| 2010-12-31 | CELG | Option Ex | 59,144 | .00 | 0 |
| 2010-09-08 | CELG | Option Ex | 169,016 | 42.39 | 7,164,588 |
| 2009-09-14 | CELG | Option Ex | 600,000 | 6.45 | 3,868,800 |
| 2009-09-14 | CELG | Sale | 600,000 | 52.12 | 31,274,400 |
| 2008-10-30 | CELG | Sale | 250,388 | 63.38 | 15,869,090 |
| 2008-09-29 | CELG | Option Ex | 15,784 | 13.42 | 211,773 |
| 2008-07-30 | CELG | Sale | 80,000 | 73.73 | 5,898,080 |
| 2008-05-12 | CELG | Option Ex | 903,128 | 12.85 | 11,603,388 |
| 2008-05-12 | CELG | Sale | 903,128 | 61.78 | 55,798,860 |
| 2008-01-02 | CELG | Option Ex | 119,728 | .71 | 85,366 |
| 2007-12-10 | CELG | Option Ex | 7,892 | 13.42 | 105,886 |
| 2007-06-07 | CELG | Sale | 453,770 | 59.14 | 26,836,865 |
| 2007-06-08 | CELG | Sale | 10,000 | 58.00 | 580,000 |
| 2006-12-21 | CELG | Option Ex | 187,868 | 15.25 | 2,865,550 |
| 2006-06-20 | CELG | Option Ex | 1,137,444 | 11.75 | 13,367,241 |
| 2006-04-07 | CELG | Option Ex | 20,884 | 9.77 | 203,932 |
Table 4. Insider trading of Amicus Therapeutics, Inc. (FOLD) by Barer Sol J
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2013-03-15 | FOLD | Buy | 25,000 | 3.40 | 85,000 |
| 2009-11-04 | FOLD | Buy | 20,000 | 4.13 | 82,600 |
Table 5. Insider trading of Aevi Genomic Medicine, Llc (GNMX) by Barer Sol J
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2019-12-05 | GNMX | Sale | 4,098,752 | .13 | 549,232 |
| 2018-08-15 | GNMX | Buy | 2,551,020 | .96 | 2,448,979 |
| 2017-10-17 | GNMX | Buy | 421,032 | 1.26 | 530,500 |
| 2017-04-28 | GNMX | Buy | 100,000 | 1.57 | 156,700 |
| 2017-04-26 | GNMX | Buy | 100,000 | 1.54 | 154,300 |
| 2015-10-06 | MDGN | Buy | 153,846 | 6.50 | 999,999 |
| 2015-03-20 | MDGN | Buy | 50,000 | 8.45 | 422,499 |
| 2015-02-20 | MDGN | Buy | 50,000 | 7.55 | 377,500 |
| 2015-02-19 | MDGN | Buy | 100,000 | 7.38 | 738,000 |
| 2014-12-01 | MDGN | Buy | 365,854 | 4.10 | 1,500,001 |
| 2014-06-13 | MDGN | Buy | 28,000 | 7.96 | 222,936 |
| 2014-05-12 | MDGN | Buy | 60,000 | 6.91 | 414,300 |
| 2013-12-13 | MDGN | Buy | 20,000 | 5.37 | 107,420 |
| 2013-12-02 | MDGN | Buy | 20,000 | 6.59 | 131,780 |
| 2013-11-11 | MDGN | Buy | 25,000 | 6.80 | 170,125 |
| 2013-09-20 | MDGN | Buy | 20,000 | 6.50 | 130,000 |
| 2013-09-19 | MDGN | Buy | 20,000 | 5.57 | 111,480 |
Table 6. Insider trading of Inspiremd, Inc. (NSPR) by Barer Sol J
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2016-03-21 | NSPR | Buy | 847,458 | .59 | 500,000 |
| 2015-03-09 | NSPR | Buy | 2,500,000 | .00 | 0 |
| 2014-11-07 | NSPR | Buy | 192,308 | .00 | 0 |
| 2014-05-12 | NSPR | Buy | 4,800 | 2.42 | 11,601 |
| 2014-05-13 | NSPR | Buy | 45,200 | 2.44 | 110,514 |
| 2013-05-31 | NSPR | Buy | 20,000 | 2.26 | 45,199 |
| 2013-05-30 | NSPR | Buy | 20,000 | 2.07 | 41,400 |
| 2013-05-29 | NSPR | Buy | 20,000 | 2.09 | 41,800 |
| 2013-05-28 | NSPR | Buy | 20,000 | 2.15 | 43,000 |
| 2013-05-24 | NSPR | Buy | 20,000 | 2.10 | 42,000 |
| 2013-04-25 | NSPR | Buy | 50,000 | 2.00 | 100,000 |
| 2013-04-16 | NSPR | Buy | 750,000 | 2.00 | 1,500,000 |
| 2012-11-21 | NSPR.OB | Buy | 34,980 | 1.33 | 46,523 |
| 2012-11-20 | NSPR.OB | Buy | 15,020 | 1.29 | 19,450 |
| 2012-11-19 | NSPR.OB | Buy | 14,441 | 1.38 | 19,986 |
| 2012-11-16 | NSPR.OB | Buy | 35,559 | 1.27 | 45,088 |
| 2011-09-28 | NSPR.OB | Option Ex | 1,000,000 | 1.50 | 1,500,000 |
Table 7. Insider trading of Teva Pharmaceutical Industries Ltd (TEVA) by Barer Sol J
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2024-06-15 | TEVA | Option Ex | 37,598 | .00 | 0 |
| 2023-08-04 | TEVA | Option Ex | 28,162 | .00 | 0 |
| 2022-06-14 | TEVA | Option Ex | 25,791 | .00 | 0 |
| 2021-06-09 | TEVA | Option Ex | 22,565 | .00 | 0 |
| 2020-08-11 | TEVA | Option Ex | 23,133 | .00 | 0 |
| 2020-06-11 | TEVA | Option Ex | 31,388 | .00 | 0 |
| 2020-02-14 | TEVA | Option Ex | 2,470 | .00 | 0 |
| 2019-06-04 | TEVA | Buy | 104,500 | 9.60 | 1,003,409 |
| 2019-06-03 | TEVA | Buy | 111,000 | 8.98 | 997,001 |
| 2019-05-16 | TEVA | Option Ex | 2,780 | .00 | 0 |
| 2018-09-03 | TEVA | Option Ex | 2,162 | .00 | 0 |
Table 8. Insider trading of Contrafect Corp (CFRX) by Barer Sol J
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2017-07-25 | CFRX | Buy | 40,000 | 1.24 | 49,600 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Barer Sol J
(Officer of Teva Pharmaceutical Industries Ltd at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.